Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

被引：87

作者：

Jacobson, Caron

Chavez, Julio C.

Sehgal, Alison R.

William, Basem M.

Munoz, Javier

Salles, Gilles

Munshi, Pashna N.

Casulo, Carla

Maloney, David

De Vos, Sven

Reshef, Ran

Leslie, Lori A.

Yakoub-Agha, Ibrahim

Oluwole, Olalekan O.

Fung, Henry C. H.

Rosenblatt, Joseph D.

Rossi, John M.

Goyal, Lovely

Plaks, Vicki

Yang, Yin

Lee, Jennifer

Godfrey, Wayne

Vezan, Remus

Avanzi, Mauro P.

Neelapu, Sattva S.

机构：

来源：

BLOOD | 2020年 / 136卷

关键词：

D O I：

10.1182/blood-2020-136834

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Interim Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL)
Jacobson, Caron A.
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Casulo, Carla
Munshi, Pashna N.
Maloney, David G.
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C.
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Avanzi, Mauro P.
Neelapu, Sattva S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S278 - S278
[2] Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL).
Jacobson, Caron A.
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles A.
Casulo, Carla
Munshi, Pashna N.
Maloney, David G.
De Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C.
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Avanzi, Mauro P.
Neelapu, Sattva Swarup
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[3] Retreatment With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma in ZUMA-5
Chavez, Julio C.
Jacobson, Caron A.
Sehgal, Alison R.
Neelapu, Sattva S.
Maloney, David G.
Salles, Gilles
William, Basem M.
Yang, Yin
Goyal, Lovely
Chou, Justin
Plaks, Vicki
Avanzi, Mauro P.
BLOOD, 2020, 136
[4] 3-Year Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/ Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Neelapu, Sattva S.
Chavez, Julio
Sehgal, Alison R.
Epperla, Narendranath
Ulrickson, Matthew
Bachy, Emanuel
Munshi, Pashna N.
Casulo, Carla
Maloney, David G.
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Oluwole, Olalekan O.
Yakoub-Agha, Ibrahim
Khanal, Rashmi
Rosenblatt, Joseph D.
Yan, Jiali
Song, Qinghua
Peng, Weixin
Lui, Christine
Wulff, Jacob
Shen, Rhine R.
Poddar, Soumya
Miao, Harry
Beygi, Sara
Jacobson, Caron A.
BLOOD, 2022, 140 : 10380 - 10383
[5] Interim Analysis of ZUMA-5: a Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.
Jacobson, Caron
Chavez, Julio
Sehgal, Alison
William, Basem
Munoz, Javier
Salles, Gilles
Casulo, Carla
Munshi, Pashna
Maloney, David
de Vos, Sven
Reshef, Ran
Leslie, Lori
Yakoub-Agha, Ibrahim
Oluwole, Olalekan
Fung, Henry Chi Hang
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Avanzi, Mauro
Neelapu, Sattva
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S20 - S21
[6] Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non- Hodgkin Lymphoma (iNHL)
Neelapu, Sattva S.
Chavez, Julio C.
Sehgal, Alison R.
Epperla, Narendranath
Ulrickson, Matthew L.
Bachy, Emmanuel
Munshi, Pashna N.
Casulo, Carla
Maloney, David G.
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Oluwole, Olalekan O.
Yakoub-Agha, Ibrahim
Khanal, Rashmi
Rosenblatt, Joseph D.
Sherman, Marika
Dong, Jinghui
Giovanetti, Alessandro
Yang, Yin
Lui, Christine
Bashir, Zahid
Jung, A. Scott
Jacobson, Caron
BLOOD, 2021, 138
[7] Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5.
Chavez, Julio C.
Jacobson, Caron A.
Sehgal, Alison
Neelapu, Sattva Swarup
Maloney, David G.
Salles, Gilles A.
William, Basem M.
Yang, Yin
Goyal, Lovely
Chou, Justin
Plaks, Vicki
Avanzi, Mauro P.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8] Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Jacobson, Caron
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C. H.
Rosenblatt, Joseph D.
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Godfrey, Wayne
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 8 - 9
[9] Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Jacobson, Caron
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C. H.
Rosenblatt, Joseph D.
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Godfrey, Wayne
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 5 - 6
[10] Primary analysis of ZUMA-5: A phase 2 study of axicabtagene ciloleucel in patients with relapsed/refractory indolent non-hodgkin lymphoma
Jacobson, Caron A.
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David G.
De Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry Chi Hang
Rosenblatt, Joseph
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Godfrey, Wayne
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 34 - 36

← 1 2 3 4 5 →